| The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis JJ Carlson, JA Roth Breast cancer research and treatment 141, 13-22, 2013 | 257 | 2013 |
| Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States JA Roth, SD Sullivan, VW Lin, A Bansal, AG Purdum, L Navale, P Cheng, ... Journal of medical economics 21 (12), 1238-1245, 2018 | 111 | 2018 |
| Value and affordability of CAR T-cell therapy in the United States S Fiorenza, DS Ritchie, SD Ramsey, CJ Turtle, JA Roth Bone marrow transplantation 55 (9), 1706-1715, 2020 | 107 | 2020 |
| A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice DL Veenstra, JA Roth, LP Garrison Jr, SD Ramsey, W Burke Genetics in Medicine 12 (11), 686-693, 2010 | 95 | 2010 |
| Prognostic Role of ERCC1 in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis JA Roth, JJ Carlson Clinical lung cancer 12 (6), 393-401, 2011 | 93 | 2011 |
| A qualitative study exploring why individuals opt out of lung cancer screening L Carter-Harris, S Brandzel, KJ Wernli, JA Roth, DSM Buist Family practice 34 (2), 239-244, 2017 | 87 | 2017 |
| Economic analysis of prostate-specific antigen screening and selective treatment strategies JA Roth, R Gulati, JL Gore, MR Cooperberg, R Etzioni JAMA oncology 2 (7), 890-898, 2016 | 87 | 2016 |
| Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study JA Roth, R Etzioni, TM Waters, M Pettinger, JE Rossouw, GL Anderson, ... Annals of internal medicine 160 (9), 594-602, 2014 | 66 | 2014 |
| Cost-effectiveness of a computerized provider order entry system in improving medication safety ambulatory care SH Forrester, Z Hepp, JA Roth, HS Wirtz, EB Devine Value in Health 17 (4), 340-349, 2014 | 55 | 2014 |
| Genetic risk factors for major bleeding in patients treated with warfarin in a community setting JA Roth, D Boudreau, MM Fujii, FM Farin, AE Rettie, KE Thummel, ... Clinical Pharmacology & Therapeutics 95 (6), 636-643, 2014 | 50 | 2014 |
| Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics JJ Carlson, R Thariani, J Roth, J Gralow, NL Henry, L Esmail, P Deverka, ... Medical Decision Making 33 (4), 463-471, 2013 | 47 | 2013 |
| Model-based estimation of colorectal cancer screening and outcomes during the COVID-19 pandemic RB Issaka, P Taylor, A Baxi, JM Inadomi, SD Ramsey, J Roth JAMA Network Open 4 (4), e216454-e216454, 2021 | 42 | 2021 |
| Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting JA Roth, K Bradley, KE Thummel, DL Veenstra, D Boudreau Pharmacoepidemiology and drug safety 24 (6), 619-627, 2015 | 40 | 2015 |
| A qualitative study exploring patient motivations for screening for lung cancer JA Roth, L Carter-Harris, S Brandzel, DSM Buist, KJ Wernli PLoS One 13 (7), e0196758, 2018 | 34 | 2018 |
| Projected clinical, resource use, and fiscal impacts of implementing low-dose computed tomography lung cancer screening in Medicare JA Roth, SD Sullivan, BHL Goulart, A Ravelo, JC Sanderson, SD Ramsey Journal of Oncology Practice 11 (4), 267-272, 2015 | 34 | 2015 |
| Safety and costs of endobronchial ultrasound-guided nodal aspiration and mediastinoscopy FC Verdial, KS Berfield, DE Wood, MS Mulligan, JA Roth, DO Francis, ... Chest 157 (3), 686-693, 2020 | 32 | 2020 |
| The reach and feasibility of an interactive lung cancer screening decision aid delivered by patient portal A Dharod, C Bellinger, K Foley, LD Case, D Miller Applied Clinical Informatics 10 (01), 019-027, 2019 | 30 | 2019 |
| Cost-effectiveness of gemcitabine+ cisplatin vs. gemcitabine monotherapy in advanced biliary tract cancer JA Roth, JJ Carlson Journal of gastrointestinal cancer 43, 215-223, 2012 | 28 | 2012 |
| The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative R Yung, RM Ray, J Roth, L Johnson, G Warnick, GL Anderson, ... Breast cancer research and treatment 180, 747-757, 2020 | 27 | 2020 |
| Impact of body mass index and genetics on warfarin major bleeding outcomes in a community setting R Hart, DL Veenstra, DM Boudreau, JA Roth The American journal of medicine 130 (2), 222-228, 2017 | 23 | 2017 |
